Blog Topic
Health Economics
Making adherence work for your dollar (or pound, or euro…)
Discover how adherence is being incorporated into health economics research and how it can affect public health policy decisions
The “other drug costs” – Part 1: non-adherence
Explore the impact of patient adherence on healthcare costs and the role health economists can play in improving medication compliance
Understanding study design in comparing drug studies
Learn about the significance of analytical methods in drug studies and how they can affect the interpretation of results
Sorting out the varying standards for pharmacoeconomic guidelines
A look at the differences in pharmacoeconomic evaluation standards and their implications
Presenteeism and the impact of appropriate pharmaceutical treatment on workplace costs
Exploring the role of pharmaceuticals in presenteeism
ASHE revisited
Explore the American Society of Health Economists (ASHE) one year after its first conference
Health economists’ broader role in lifestyles, demographics, and risk management
The influence of economists in lifestyle and demographic issues
Risk/benefit decisions – who should be involved, and are there valid measurement methods?
An overview of approaches to include patient preferences in treatment decision-making processes
Industry commentary – Compulsory licences in Thailand override international patents
Merck cuts the price of Efavirenz in Thailand due to compulsory licences for generics, sparking a debate on the patent system and innovation
Profile: Health policy academics Jennifer Lofland and Laura Pizzi
A look at health economics & its growing role in the US
How Australia’s drug approval process works
Understanding TGA regulations for therapeutic goods in Australia
Subscribe to our newsletter
Get the latest news straight to your inbox.
Discover the Power of Communication with Rx
Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.
